Canada Life’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $370K | Sell |
11,364
-17,015
| -60% | -$554K | ﹤0.01% | 1650 |
|
|
2025
Q1 | $1.07M | Hold |
28,379
| – | – | ﹤0.01% | 1410 |
|
|
2024
Q4 | $2.32M | Buy |
28,379
+5,423
| +24% | +$443K | ﹤0.01% | 1200 |
|
|
2024
Q3 | $2.63M | Hold |
22,956
| – | – | ﹤0.01% | 1181 |
|
|
2024
Q2 | $1.74M | Buy |
22,956
+4,892
| +27% | +$370K | ﹤0.01% | 1343 |
|
|
2024
Q1 | $1.23M | Buy |
18,064
+11,208
| +163% | +$766K | ﹤0.01% | 1447 |
|
|
2023
Q4 | $428K | Sell |
6,856
-6,110
| -47% | -$381K | ﹤0.01% | 1731 |
|
|
2023
Q3 | $660K | Buy |
12,966
+3,596
| +38% | +$183K | ﹤0.01% | 1611 |
|
|
2023
Q2 | $471K | Buy |
9,370
+6,712
| +253% | +$337K | ﹤0.01% | 1703 |
|
|
2023
Q1 | $100K | Hold |
2,658
| – | – | ﹤0.01% | 1981 |
|
|
2022
Q4 | $128K | Buy |
2,658
+848
| +47% | +$40.8K | ﹤0.01% | 1942 |
|
|
2022
Q3 | $43K | Hold |
1,810
| – | – | ﹤0.01% | 2125 |
|
|
2022
Q2 | $39K | Buy |
1,810
+741
| +69% | +$16K | ﹤0.01% | 2106 |
|
|
2022
Q1 | $27K | Hold |
1,069
| – | – | ﹤0.01% | 2299 |
|
|
2021
Q4 | $25K | Hold |
1,069
| – | – | ﹤0.01% | 2334 |
|
|
2021
Q3 | $27K | Hold |
1,069
| – | – | ﹤0.01% | 2380 |
|
|
2021
Q2 | $24K | Hold |
1,069
| – | – | ﹤0.01% | 2447 |
|
|
2021
Q1 | $21K | Hold |
1,069
| – | – | ﹤0.01% | 2498 |
|
|
2020
Q4 | $28K | Buy |
+1,069
| New | +$28K | ﹤0.01% | 2477 |
|